BetaThis is a new service - your feedback will help us to improve it.
Information
COVID-19 deaths data will be published next week
There will be a delay to the publication of the COVID-19 deaths data because of the Easter bank holidays. The Office of National Statistics (ONS) will publish the latest data on Friday 25 April. As a result, the data will appear on the dashboard on 1 May.
Entry title:
Lead exposure in children
Last updated on Thursday, 24 April 2025 at 05:06pm
Lead is a persistent heavy metal environmental contaminant that adversely affects health, even at low blood lead concentrations. There is no known safe threshold for lead exposure. Children and the foetus (thus pregnant women) are particularly vulnerable to the health impacts of lead exposure.
Lead Exposure in Children Surveillance System (LEICSS) is a passive surveillance system that notifies the Health Protection Teams (HPTs) of laboratory reports of elevated blood lead levels in children aged 0 to 15 years in England. This system facilitates effective health protection case management which primarily involves identifying and removing the individual from the source(s) of lead. Since 5 July 2021, the case definition for surveillance changed to half the original concentration, from 0.48 μmol/L (equivalent to ≥10μg/dL) to 0.24μmol/L (equivalent to ≥5μg/dL). As expected, this led to a steep increase in the number of cases being reported to LEICSS.
Cases recorded by LEICSS come from several sources. The majority are reported directly to LEICSS by UK Accreditation Service (UKAS) accredited testing biochemistry or toxicology laboratories. These are then processed by LEICSS, recorded in the UKHSA case management system (CIMS) and referred to the HPT of residence for case management. A smaller number of cases of elevated blood lead are notified directly to Health Protection Teams (HPT), for example via the clinician caring for the child.
Annual reports are published each year to provide insights into the prevailing trends in case numbers and characteristics. This data will next be updated in winter 2025.
Counts of LEICSS cases reported by year. A change in case definition since 2021 has led to a steep increase in the number of cases being reported. Figures are annual, but shown as at December of each year. For example, the figures for 2023 are shown as at "Dec 2023".
Cases by year data for counts of LEICSS cases reported by year. A change in case definition since 2021 has led to a steep increase in the number of cases being reported. Figures are annual, but shown as at December of each year. For example, the figures for 2023 are shown as at "Dec 2023".
Up to and including 31 December 2023
Year
Number of cases
31 Dec 2023
226
31 Dec 2022
191
31 Dec 2021
121
31 Dec 2020
35
31 Dec 2019
36
31 Dec 2018
45
31 Dec 2017
49
31 Dec 2016
33
31 Dec 2015
33
Download
About
NOTES:
A case is defined as a child with a blood lead concentration ≥0.24 μmol/L (equivalent to ≥5 μg/dL) detected in a UK Accreditation Service (UKAS) accredited biochemistry or toxicology laboratory. This is reported to UKHSA for public health intervention. The child is aged under 16 years at the time elevated levels of lead are detected in the blood and resident of England.
Prior to 5 July 2021, the case definition for surveillance was 0.48 μmol/L (equivalent to ≥10μg/dL).
Since 5 July 2021, the case definition for surveillance changed to half the original concentration to 0.24μmol/L (equivalent to ≥5μg/dL). As expected, this led to a steep increase in the number of cases being reported to LEICSS.
Average detection rates by UKHSA Region
The rate of LEICSS cases reported across the nine UKHSA regions in England. A change in case definition since 2021 has led to a steep increase in the number of cases being reported. Regions with participating laboratories are denoted with an asterisk (*) in the legend below. Figures are annual, but shown as at December of each year. For example, the figures for 2023 are shown as at "Dec 2023".
Average detection rates by UKHSA Region data for the rate of LEICSS cases reported across the nine UKHSA regions in England. A change in case definition since 2021 has led to a steep increase in the number of cases being reported. Regions with participating laboratories are denoted with an asterisk (*) in the legend below. Figures are annual, but shown as at December of each year. For example, the figures for 2023 are shown as at "Dec 2023".
Up to and including 31 December 2023
Year
East of England
East Midlands
31 Dec 2023
8.22
14.42
31 Dec 2022
5.05
11.35
31 Dec 2021
3.13
0
31 Dec 2020
3.1
3.3
31 Dec 2019
2.35
1.11
31 Dec 2018
3.17
3.36
31 Dec 2017
1.6
0
31 Dec 2016
4.05
0
31 Dec 2015
2.46
1.16
Year
West Midlands*
London*
31 Dec 2023
25.49
17.74
31 Dec 2022
33.11
14.19
31 Dec 2021
9.41
10.84
31 Dec 2020
1.7
2.2
31 Dec 2019
0
5.97
31 Dec 2018
3.45
6.54
31 Dec 2017
2.61
5.52
31 Dec 2016
2.64
3.9
31 Dec 2015
1.78
2.84
Year
South East*
South West*
31 Dec 2023
13.05
16.41
31 Dec 2022
5.8
9.32
31 Dec 2021
4.1
9.07
31 Dec 2020
0
3
31 Dec 2019
0.59
2.02
31 Dec 2018
1.77
4.05
31 Dec 2017
2.39
2.05
31 Dec 2016
0
0
31 Dec 2015
3.65
2.09
Year
North West
North East
31 Dec 2023
12.67
16.87
31 Dec 2022
18.7
6.41
31 Dec 2021
7.82
10.47
31 Dec 2020
3.6
4.2
31 Dec 2019
8.38
0
31 Dec 2018
2.15
0
31 Dec 2017
7.96
2.12
31 Dec 2016
4.39
0
31 Dec 2015
2.96
2.15
Year
Yorkshire and Humber*
31 Dec 2023
75.48
31 Dec 2022
63.81
31 Dec 2021
51.4
31 Dec 2020
11.4
31 Dec 2019
13.33
31 Dec 2018
11.47
31 Dec 2017
15.42
31 Dec 2016
11.67
31 Dec 2015
8.83
Download
About
NOTES:
A case is defined as a child with a blood lead concentration ≥0.24 μmol/L (equivalent to ≥5 μg/dL) detected in a UK Accreditation Service (UKAS) accredited biochemistry or toxicology laboratory. This is reported to UKHSA for public health intervention. The child is aged under 16 years at the time elevated levels of lead are detected in the blood and resident of England.
Prior to 5 July 2021, the case definition for surveillance was 0.48 μmol/L (equivalent to ≥10μg/dL).
Since 5 July 2021, the case definition for surveillance changed to half the original concentration to 0.24μmol/L (equivalent to ≥5μg/dL). As expected, this led to a steep increase in the number of cases being reported to LEICSS.
Detection rate by age and sex - males
Detection rate is calculated as the number of cases per 1,000,000 children. Data for 2015 to 2023.
Detection rate by age and sex - females data for detection rate is calculated as the number of cases per 1,000,000 children. Data for 2015 to 2023.
Up to and including 31 December 2023
Females
< 1 year
< 1 year
6
Females
01-04 years
< 1 year
13.5
Females
05-11 years
< 1 year
2.6
Females
12-15 years
< 1 year
0.6
Download
Cases by deprivation, 2015 to 2022
The percentage of LEICSS cases by quintile of the Index of Multiple Deprivation (IMD), highlighting case distribution across severity of deprivation index quintile. Quintile 1 represents the least deprived regions while quintile 5 represents the most deprived regions.
Cases by deprivation, 2015 to 2022 data for the percentage of LEICSS cases by quintile of the Index of Multiple Deprivation (IMD), highlighting case distribution across severity of deprivation index quintile. Quintile 1 represents the least deprived regions while quintile 5 represents the most deprived regions.
Up to and including 31 December 2023
Deprivation quintile
Percent of cases
1
4.2
2
10
3
13.7
4
21.5
5
50.5
Download
Cases by deprivation, 2023
The percentage of LEICSS cases by quintile of the Index of Multiple Deprivation (IMD), highlighting case distribution across severity of deprivation index quintile. Quintile 1 represents the least deprived regions while quintile 5 represents the most deprived regions.
Cases by deprivation, 2023 data for the percentage of LEICSS cases by quintile of the Index of Multiple Deprivation (IMD), highlighting case distribution across severity of deprivation index quintile. Quintile 1 represents the least deprived regions while quintile 5 represents the most deprived regions.